NCT02740231View on ClinicalTrials.gov

A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions
Knee Osteoarthritis
Interventions
DRUG

JTA-004 intra-articular injection

Each patient will undergo a single injection of JTA-004 into the knee joint

DEVICE

Reference product intra-articular injection

Each patient will undergo a single injection of Reference product into the knee joint

Sponsors
All Listed Sponsors
lead

Bone Therapeutics S.A

INDUSTRY